The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies
- 1 July 2003
- journal article
- research article
- Published by Elsevier BV in Surgical Oncology Clinics of North America
- Vol. 12 (3), 673-688
- https://doi.org/10.1016/s1055-3207(03)00034-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosisThe Lancet Oncology, 2002
- The cellular and molecular basis of hyperthermiaCritical Reviews in Oncology/Hematology, 2002
- Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosisEuropean Journal of Surgical Oncology, 2001
- Limitations of peritoneal lavage with antiseptics in prevention of recurrent colorectal cancer caused by tumor-cell seedingDiseases of the Colon & Rectum, 2000
- Intraperitoneal chemotherapy in ovarian cancerCancer Treatment Reviews, 2000
- Appendiceal Malignancy: Where Do We Stand?Annals of Surgical Oncology, 1999
- Prognostic Factors in Extraovarian Primary Peritoneal CarcinomaGynecologic Oncology, 1998
- Irrigation does not dislodge or destroy tumor cells adherent to the tumor bedJournal of Surgical Oncology, 1993
- Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in ratsEuropean Journal of Cancer and Clinical Oncology, 1991
- Surgical biopsy studies of omental and peritoneal nodulesBritish Journal of Surgery, 1971